Display options
Cite
Abdrakhmanov A, Yapryntseva MA, Kaminskyy VO, et al. Receptor-Mediated Mitophagy Rescues Cancer Cells under Hypoxic Conditions. Cancers (Basel). 2021;13(16)doi: 10.3390/cancers13164027.
Abdrakhmanov, A., Yapryntseva, M. A., Kaminskyy, V. O., Zhivotovsky, B., & Gogvadze, V. (2021). Receptor-Mediated Mitophagy Rescues Cancer Cells under Hypoxic Conditions. Cancers, 13(16), . https://doi.org/10.3390/cancers13164027
Abdrakhmanov, Alibek, et al. "Receptor-Mediated Mitophagy Rescues Cancer Cells under Hypoxic Conditions." Cancers vol. 13,16 (2021). doi: https://doi.org/10.3390/cancers13164027
Abdrakhmanov A, Yapryntseva MA, Kaminskyy VO, Zhivotovsky B, Gogvadze V. Receptor-Mediated Mitophagy Rescues Cancer Cells under Hypoxic Conditions. Cancers (Basel). 2021 Aug 10;13(16). doi: 10.3390/cancers13164027. PMID: 34439183; PMCID: PMC8394032.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2021 Aug 10;13(16). doi: 10.3390/cancers13164027.

Receptor-Mediated Mitophagy Rescues Cancer Cells under Hypoxic Conditions.

Cancers

Alibek Abdrakhmanov, Maria A Yapryntseva, Vitaliy O Kaminskyy, Boris Zhivotovsky, Vladimir Gogvadze

Affiliations

  1. Faculty of Medicine, MV Lomonosov Moscow State University, 119991 Moscow, Russia.
  2. Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden.

PMID: 34439183 PMCID: PMC8394032 DOI: 10.3390/cancers13164027

Abstract

Targeting mitochondria with thenoyltrifluoroacetone (TTFA), an inhibitor of Complex II in the respiratory chain, stimulated cisplatin-induced apoptosis in various cell lines in normoxia but not in hypoxia. This can be explained by the elimination of mitochondria involved in triggering apoptotic cell death by mitophagy, either Parkin-dependent or receptor-mediated. Treatment with TTFA alone or in combination with cisplatin did not cause accumulation of PINK1, meaning that under hypoxic conditions cells survive through activation of a receptor-mediated pathway. Hypoxia triggers the accumulation of BNIP3 and BNIP3L (also known as NIX), key participants in receptor-mediated mitophagy. Under hypoxic conditions, stimulation of autophagy, as assessed by the accumulation of lipidated form of LC3 (LC3II), was observed. To exclude the contribution of canonical macroautophagy in LC3II accumulation, experiments were performed using U1810 cells lacking ATG13, a key enzyme of macroautophagy. Despite the absence of ATG13, hypoxia-mediated accumulation of LC3II was not affected, underlying the importance of the receptor-mediated pathway. In order to prove the protective role of BNIP3 against cisplatin-induced apoptosis, BNIP3-deficient A549 cells were used. Surprisingly, a BNIP3 knockout did not abolish hypoxia-induced protection; however, in cells lacking BNIP3, a compensatory upregulation of BNIP3L was detected. Thus, in the absence of BNIP3, mitophagy could be maintained by BNIP3L and lead to cell death suppression due to the elimination of proapoptotic mitochondria. When both BNIP3 and BNIP3L were knocked out, the inhibitory effect of hypoxia on apoptosis was diminished, although not abolished completely. Undoubtedly, receptor-mediated mitophagy is likely to be one of the mechanisms responsible for cell death suppression under hypoxic conditions.

Keywords: autophagy; cancer; cell death; hypoxia; mitochondria; mitophagy

References

  1. Biochim Biophys Acta. 2016 Aug;1863(8):2065-71 - PubMed
  2. J Biol Chem. 2012 Jun 1;287(23):19094-104 - PubMed
  3. Front Physiol. 2017 Jul 26;8:539 - PubMed
  4. J Biol Chem. 1998 May 8;273(19):11401-4 - PubMed
  5. Curr Biol. 2016 Mar 7;26(5):R207-9 - PubMed
  6. Hypoxia (Auckl). 2015 Dec 11;3:83-92 - PubMed
  7. Biol Chem. 2019 Jan 28;400(2):161-170 - PubMed
  8. Chem Biol Interact. 2021 Aug 25;345:109553 - PubMed
  9. Cell Death Differ. 2015 Feb;22(2):248-57 - PubMed
  10. Autophagy. 2021 May;17(5):1232-1243 - PubMed
  11. Autophagy. 2011 Dec;7(12):1423-33 - PubMed
  12. FASEB J. 2009 Oct;23(10):3405-14 - PubMed
  13. Biochim Biophys Acta. 2013 Dec;1834(12):2750-60 - PubMed
  14. Annu Rev Cell Dev Biol. 2011;27:107-32 - PubMed
  15. Cell Death Differ. 2009 Jul;16(7):939-46 - PubMed
  16. Nat Commun. 2015 Jul 06;6:7527 - PubMed
  17. EMBO Rep. 2017 Jun;18(6):947-961 - PubMed
  18. Trends Cell Biol. 2016 Oct;26(10):733-744 - PubMed

Publication Types

Grant support